Ad
APRI - Apricus Biosciences Stock Trading
About | Apricus Biosciences Inc. (NASDAQ:APRI)
Not available
Quote | Apricus Biosciences Inc. (NASDAQ:APRI)
| Last: | $ |
|---|---|
| Change Percent: | -2.87% |
| Open: | $0.23 |
| Close: | $0.22 |
| High: | $0.23 |
| Low: | $0.2069 |
| Volume: | 1,101,864 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Apricus Biosciences Inc. (NASDAQ:APRI)
-
Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by...
-
Apricus Biosciences (NASDAQ: APRI ): Q3 GAAP EPS of -$0.12. More news on: Apricus Biosciences, Inc, Earnings news and commentary, Healthcare stocks news, , Read more ...
Message Board Posts | Apricus Biosciences Inc. (NASDAQ:APRI)
| Subject | By | Source | When |
|---|---|---|---|
| one more thing : my other message is | smul | investorshub | 08/31/2022 8:28:07 PM |
| invest in seel for another 9 months, be | smul | investorshub | 08/31/2022 8:22:18 PM |
| Seelos Therapeutics Receives a Research and Development Grant | harr449 | investorshub | 08/24/2022 4:32:37 PM |
| Yep. Nice to see it finally back | Invest83838 | investorshub | 08/18/2022 11:45:21 PM |
| still needs to go up for 150%, but | smul | investorshub | 08/18/2022 6:50:45 PM |
Apricus Biosciences Inc. Company Name:
APRI Stock Symbol:
NASDAQ Market:
Apricus Biosciences Inc. Website:
Ad
-
Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by...
-
Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus Shareholders Expected to Own ~15% of Estimated $94 Million Combined Company Valuation at Closing SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a bioph...